Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-17-000912
Filing Date
2017-01-05
Accepted
2017-01-05 21:52:45
Documents
2
Period of Report
2017-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 8148
2 poa_kapusta.htm EX-24 9483
  Complete submission text file 0001140361-17-000912.txt   18940
Mailing Address 7358 MCVAY ROAD GERMANTOWN TN 38138
Business Address
Kapusta Matthew C (Reporting) CIK: 0001536290 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36294 | Film No.: 17512786

Mailing Address MEIBERGDREFF 61 AMSTERDAM P7 1005 BA
Business Address MEIBERGDREFF 61 AMSTERDAM P7 1005 BA 31-20-5667394
uniQure N.V. (Issuer) CIK: 0001590560 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations